Search
Determination of bromhexine and its metabolites in equine serum samples by liquid chromatography – Tandem mass spectrometry: Applicability to the elimination study after single oral dose
Abstract
Bromhexine (BH), expectorant used in the treatment of respiratory disorders associated with viscid or excessive mucus, is not permitted for use in the competing horse by many authorities in horseracing and Olympic disciplines. Metabolic studies are of the great importance in anti-doping field because they allow for updating the selection of the most appropriate markers for prohibited substances, such as metabolites present at higher concentration levels and/or lasted for a longer period of time in biological samples than a parent drug. This study describes LC-MS/MS-based method for simultaneous determination of BH and its metabolites, including 4-(2-amino-3,5-dibromobenzylamino)cyclohexanol (4-HDMB), 3-(2-amino-3,5-dibromobenzylamino)cyclohexanol (3-HDMB), in equine serum samples. The 2-(2-amino-3,5-dibromobenzylamino)cyclohexanol (2-HDMB) was monitored as well. The assay was validated in terms of linearity (R2 greater than 0.9951), intra- and inter-assay accuracy (91.6 – 109.1%) and precision (CV < 9.6%) as well as recovery (94.8 – 105.65%). The LODs were 0.0052, 0.0053, 0.0056 and 0.0043 ng/mL for BH, 2-HDMB, 3-HDMB and 4-HDMB, respectively. The developed method was applied to determine the time curses of BH and its metabolites concentrations in equine serum collected for 95.25 h following a single oral administration of BH to two healthy mares (in dose of 0.8 mg/kg). The parent drug was found at higher concentration levels than 3-HDMB (major metabolite) and 4-HDMB (minor metabolite), however, both BH metabolites lasted for a longer period of time in equine serum than the parent drug. Thus, both metabolites of BH can be considered as BH abuse markers.
Citations
-
2
CrossRef
-
0
Web of Science
-
3
Scopus
Authors (8)
-
Ewa Kłodzińska dr. hab.
-
Mariusz Ozimek
-
Robert Wrzesień
-
Barbara Bobrowska-Korczak
Cite as
Full text
- Publication version
- Accepted or Published Version
- License
-
open in new tab
Keywords
Details
- Category:
- Articles
- Type:
- artykuły w czasopismach
- Published in:
-
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
no. 1151,
ISSN: 1570-0232 - Language:
- English
- Publication year:
- 2020
- Bibliographic description:
- Waraksa E., Owczarek K., Kubica P., Kłodzińska E., Ozimek M., Wrzesień R., Bobrowska-Korczak B., Namieśnik J.: Determination of bromhexine and its metabolites in equine serum samples by liquid chromatography – Tandem mass spectrometry: Applicability to the elimination study after single oral dose// JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES -Vol. 1151, (2020), s.122197-
- DOI:
- Digital Object Identifier (open in new tab) 10.1016/j.jchromb.2020.122197
- Sources of funding:
-
- This work was supported by the Polish National Science Center [grant number 2016/21/N/ST4/02342]
- Verified by:
- Gdańsk University of Technology
seen 168 times
Recommended for you
Simultaneous determination of ibuprofen and its metabolites in complex equine urine matrices by GC-EI-MS in excretion study in view of doping control
- E. Waraksa,
- M. Wójtowicz-zawadka,
- D. Kwiatkowska
- + 4 authors